Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer

Personalized cancer medicine aims to accurately predict the response of individual patients to targeted therapies, including tyrosine kinase inhibitors (TKIs). Clinical implementation of this concept requires a robust selection tool. Here, using both cancer cell lines and tumor tissue from patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Labots, Mariette, Gotink, Kristy J, Dekker, Henk, Azijli, Kaamar, van der Mijn, Johannes C, Huijts, Charlotte M, Piersma, Sander R, Jiménez, Connie R, Verheul, Henk M W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192072/
https://www.ncbi.nlm.nih.gov/pubmed/27980342
http://dx.doi.org/10.1038/emm.2016.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192072/
https://www.ncbi.nlm.nih.gov/pubmed/27980342
http://dx.doi.org/10.1038/emm.2016.114

Ejemplares similares